Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul M Dunman

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Current Opinion in Pharmacology|October 16, 2003
Passive immunization as prophylaxis: when and where will this work?Paul M Dunman, Mirjana Nesin
Current Opinion in Microbiology|September 11, 2015
Translational deficiencies in antibacterial discovery and new screening paradigmsPaul M Dunman, Andrew P Tomaras
Current Opinion in Microbiology|September 20, 2015
Editorial overview: AntimicrobialsPaul M Dunman, Andrew P Tomaras
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2008
Target-based antimicrobial drug discoveryLefa E Alksne, Paul M Dunman
Future Microbiology|October 19, 2011
The modulation of Staphylococcus aureus mRNA turnoverJohn M Morrison, Paul M Dunman
Current Opinion in Microbiology|September 11, 2015
In the midst of the antimicrobial discovery conundrum: an overviewAndrew P Tomaras, Paul M Dunman
International Journal of Microbiology|November 26, 2009
Messenger RNA Turnover Processes in Escherichia coli, Bacillus subtilis, and Emerging Studies in Staphylococcus aureusKelsi L Anderson, Paul M Dunman
Current Opinion in Pharmacology|July 28, 2006
Staphylococcal vaccines and immunotherapy: to dream the impossible dream?Steven J Projan, Mirjana Nesin, Paul M Dunman
Molecular Microbiology|July 25, 2006
The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunityAnthony R Richardson, Paul M Dunman, Ferric C Fang
Antimicrobial Agents and Chemotherapy|August 13, 2014
Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitorsCatlyn Blanchard, Pamela Barnett, Jessamyn Perlmutter, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Current Opinion in Pharmacology|October 16, 2003
Passive immunization as prophylaxis: when and where will this work?Paul M Dunman, Mirjana Nesin
Current Opinion in Microbiology|September 11, 2015
Translational deficiencies in antibacterial discovery and new screening paradigmsPaul M Dunman, Andrew P Tomaras
Current Opinion in Microbiology|September 20, 2015
Editorial overview: AntimicrobialsPaul M Dunman, Andrew P Tomaras
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2008
Target-based antimicrobial drug discoveryLefa E Alksne, Paul M Dunman
Future Microbiology|October 19, 2011
The modulation of Staphylococcus aureus mRNA turnoverJohn M Morrison, Paul M Dunman
Current Opinion in Microbiology|September 11, 2015
In the midst of the antimicrobial discovery conundrum: an overviewAndrew P Tomaras, Paul M Dunman
International Journal of Microbiology|November 26, 2009
Messenger RNA Turnover Processes in Escherichia coli, Bacillus subtilis, and Emerging Studies in Staphylococcus aureusKelsi L Anderson, Paul M Dunman
Current Opinion in Pharmacology|July 28, 2006
Staphylococcal vaccines and immunotherapy: to dream the impossible dream?Steven J Projan, Mirjana Nesin, Paul M Dunman
Molecular Microbiology|July 25, 2006
The nitrosative stress response of Staphylococcus aureus is required for resistance to innate immunityAnthony R Richardson, Paul M Dunman, Ferric C Fang
Antimicrobial Agents and Chemotherapy|August 13, 2014
Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitorsCatlyn Blanchard, Pamela Barnett, Jessamyn Perlmutter, et al.
Pageof 11